Please login to the form below

Not currently logged in
Email:
Password:

COVID-19 testing

This page shows the latest COVID-19 testing news and features for those working in and with pharma, biotech and healthcare.

J&J completes enrolment for late-stage COVID-19 vaccine trial

J&J completes enrolment for late-stage COVID-19 vaccine trial

J&J advanced its COVID-19 vaccine candidate into phase 3 testing in September following positive interim results from a phase 1/2a clinical study of the shot. ... The pivotal late-stage study is investigating the safety and efficacy of a single vaccine

Latest news

  • J&J trims the size of its phase 3 COVID-19 vaccine trial J&J trims the size of its phase 3 COVID-19 vaccine trial

    Johnson &Johnson (J&J) announced on Wednesday that it will decrease the size of its US-based phase 3 trial currently testing its COVID-19 vaccine as cases surge across the ... J&J advanced its COVID-19 vaccine candidate into phase 3 testing in September

  • Novavax moves closer toward launch of US phase 3 COVID-19 vaccine trial Novavax moves closer toward launch of US phase 3 COVID-19 vaccine trial

    The company is expecting interim data from this trial as early as the first quarter of 2021, but this depends on the overall COVID-19 infection rate in the region. ... As Novavax seeks to move NVX-CoV2373 through late-stage testing, a number of COVID-19

  • Joint COVID-19 trial begins testing drugs from Amgen, UCB and Takeda Joint COVID-19 trial begins testing drugs from Amgen, UCB and Takeda

    Trial will test therapeutic candidates in hospitalised COVID-19 patients. The COVID-19 R&D Alliance has enrolled the first patient in a trial testing therapeutic candidates from Amgen, UCB and ... Takeda. The COMMUNITY trial is testing a number of drugs

  • J&J advances COVID-19 vaccine into second phase 3 trial J&J advances COVID-19 vaccine into second phase 3 trial

    ENSEMBLE study will enrol 60, 000 people worldwide. Johnson &Johnson (J&J) has launched a second phase 3 trial of a single-dose regimen of its COVID-19 vaccine candidate, ... AstraZeneca, which is developing its COVID-19 vaccine in conjunction with

  • AZ’s BTK inhibitor Calquence fails in COVID-19 study AZ’s BTK inhibitor Calquence fails in COVID-19 study

    This hyper inflammation can seriously harm patients with COVID-19 and can result in the death of patients. ... Aside from Calquence, AZ is also testing a late-stage COVID-19 vaccine candidate, originally developed by Oxford University researchers, which

More from news
Approximately 1 fully matching, plus 25 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
KVA Digital

KVA is an award winning full-service digital communications & brand experience agency. Our healthcare expertise blends creative ‘outside-the-box’ thinking with...

Latest intelligence

PME Jan cover
AstraZeneca’s focus on diagnosing and managing chronic kidney disease
People living with chronic kidney disease are in urgent need of new and improved approaches to diagnosis and care...
Delphi Technique Virtual Co-creation: A Customer Story
How a client leveraged the Delphi technique to co-create a consensus statement and algorithm using virtual touchpoints....
AI healthcare
Three ways AI will change healthcare in the next decade
Looking forward, there is no doubt that AI will continue to take centre stage in global healthcare initiatives...

Infographics